PGR and triple-negative breast carcinoma: The triple-negative breast cancer (TNBC) is the most aggressive subtype of breast tumours due to limited therapeutic options using targeted drugs and is biologically characterized by absence of expression of oestrogen receptor (ER), progesterone receptor (PR), and HER2 receptor.1 According to its molecular characteristics, TNBC could be classified the in six different subtypes.2